104 related articles for article (PubMed ID: 15170013)
1. Acceptability of COL-1492, a vaginal gel, among sex workers in one Asian and three African cities.
Vandebosch A; Goetghebeur E; Ramjee G; Alary M; Ettiègne-Traoré V; Chandeying V; Van Damme L;
Sex Transm Infect; 2004 Jun; 80(3):241-3. PubMed ID: 15170013
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.
Van Damme L; Ramjee G; Alary M; Vuylsteke B; Chandeying V; Rees H; Sirivongrangson P; Mukenge-Tshibaka L; Ettiègne-Traoré V; Uaheowitchai C; Karim SS; Mâsse B; Perriëns J; Laga M;
Lancet; 2002 Sep; 360(9338):971-7. PubMed ID: 12383665
[TBL] [Abstract][Full Text] [Related]
3. The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers.
Marais D; Carrara H; Kay P; Ramjee G; Allan B; Williamson AL
Virus Res; 2006 Nov; 121(2):220-2. PubMed ID: 16860426
[TBL] [Abstract][Full Text] [Related]
4. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group.
Van Damme L; Chandeying V; Ramjee G; Rees H; Sirivongrangson P; Laga M; Perriëns J
AIDS; 2000 Jan; 14(1):85-8. PubMed ID: 10714571
[TBL] [Abstract][Full Text] [Related]
5. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
[TBL] [Abstract][Full Text] [Related]
6. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa.
Rustomjee R; Abdool Karim Q; Abdool Karim SS; Laga M; Stein Z
AIDS; 1999 Aug; 13(12):1511-5. PubMed ID: 10465075
[TBL] [Abstract][Full Text] [Related]
7. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
[No Abstract] [Full Text] [Related]
8. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.
Barnhart KT; Rosenberg MJ; MacKay HT; Blithe DL; Higgins J; Walsh T; Wan L; Thomas M; Creinin MD; Westhoff C; Schlaff W; Archer DF; Ayers C; Kaunitz A; Das S; Moench TR
Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603
[TBL] [Abstract][Full Text] [Related]
9. Acceptability of five nonoxynol-9 spermicides.
Raymond EG; Chen PL; Condon S; Luoto J; Barnhart KT; Creinin MD; Poindexter A; Wan L; Martens M; Schenken R; Blackwell R
Contraception; 2005 Jun; 71(6):438-42. PubMed ID: 15914133
[TBL] [Abstract][Full Text] [Related]
10. Acceptability and feasibility of a clinical trial to assess the efficacy of a microbicide-containing vaginal gel to prevent HIV infection among female sex workers in Abidjan, Côte d'Ivoire.
Ettiègne-Traoré V; Ghys PD; Van Damme L; N'Krumah M; Maïga A; Tiémelé A; Mah-bi G; Coulibaly IM; Laga M; Greenberg AE
AIDS; 1997 Nov; 11(13):1660-2. PubMed ID: 9365779
[No Abstract] [Full Text] [Related]
11. Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives.
Witter FR; Barditch-Crovo P; Rocco L; Trapnell CB
Int J Gynaecol Obstet; 1999 May; 65(2):165-70. PubMed ID: 10405061
[TBL] [Abstract][Full Text] [Related]
12. Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. A randomized clinical trial.
Martin HL; Stevens CE; Richardson BA; Rugamba D; Nyange PM; Mandaliya K; Ndinya-Achola J; Kreiss JK
Sex Transm Dis; 1997 May; 24(5):279-83. PubMed ID: 9153737
[TBL] [Abstract][Full Text] [Related]
13. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia.
Hira SK; Feldblum PJ; Kamanga J; Mukelabai G; Weir SS; Thomas JC
Int J STD AIDS; 1997 Apr; 8(4):243-50. PubMed ID: 9147157
[TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection.
Van Damme L; Niruthisard S; Atisook R; Boer K; Dally L; Laga M; Lange JM; Karam M; Perriens JH
AIDS; 1998 Mar; 12(4):433-7. PubMed ID: 9520174
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of an optimized benzalkonium chloride gel as vaginal contraceptive: a randomized controlled trial among Chinese women.
Li W; Huang Z; Wu Y; Wang H; Zhou X; Xiao Z; Ding X; Xu J
Contraception; 2013 Jun; 87(6):756-65. PubMed ID: 23089047
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.
Kreiss J; Ngugi E; Holmes K; Ndinya-Achola J; Waiyaki P; Roberts PL; Ruminjo I; Sajabi R; Kimata J; Fleming TR
JAMA; 1992 Jul 22-29; 268(4):477-82. PubMed ID: 1320133
[TBL] [Abstract][Full Text] [Related]
17. AIDS chief says nonoxynol-9 not effective against HIV.
AIDS Wkly; 2000 Jul 10-17; ():2-3. PubMed ID: 12296062
[TBL] [Abstract][Full Text] [Related]
18. Views of Cameroonian sex workers on a woman-controlled method of contraception and disease protection.
Visness CM; Ulin P; Pfannenschmidt S; Zekeng L
Int J STD AIDS; 1998 Nov; 9(11):695-9. PubMed ID: 9863584
[TBL] [Abstract][Full Text] [Related]
19. [Current status of the female condom in Africa].
Deniaud F
Sante; 1997; 7(6):405-15. PubMed ID: 9503499
[TBL] [Abstract][Full Text] [Related]
20. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers.
Weir SS; Roddy RE; Zekeng L; Feldblum PJ
Genitourin Med; 1995 Apr; 71(2):78-81. PubMed ID: 7744418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
